| Financial Year |
March 31 2023 |
| Monetary Funds |
3,322,279,844.45 |
| Held-for-trading Financial Assets |
1,635,976,728.77 |
| Notes Receivable |
61,653,621.18 |
| Accounts Receivable |
1,240,811,803.50 |
| Advances to Suppliers |
196,883,582.79 |
| Other Receivables |
43,275,816.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,336,941,306.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
26,071,952.38 |
| Other Current Assets |
49,656,481.87 |
| Total Current Assets |
8,384,789,764.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
650,530,753.63 |
| Investment Properties |
-- |
| Fixed Assetes |
2,251,193,405.75 |
| Under-construction Projects |
134,071,153.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
709,909,213.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
55,294,058.47 |
| Deferred Income Tax Assets |
134,980,466.20 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,785,337,784.19 |
| Total Assets |
14,170,127,548.57 |
| Short-Term Loans |
270,243,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,531,013,300.68 |
| Accounts Payable |
3,631,997,173.12 |
| Accounts Received In Advance |
190,366.98 |
| Employee Compensation Payable |
100,551,324.30 |
| Taxes Payable |
21,342,554.31 |
| Interest Payable |
26,498,656.49 |
| Dividend Payable |
8,439,607.82 |
| Other payables |
354,938,807.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,197,895.56 |
| Other Current Liabilities |
633,015,930.83 |
| Sub-Total of Current Liabilities |
6,824,009,685.37 |
| Long-term Loans |
47,380,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
8,551,369.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,962,613.99 |
| Deferred Income Tax Liabilities |
114,354,586.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
351,197,000.65 |
| Total Liabilities |
7,175,206,686.02 |
| Paid-In Capital(Or Share Stock) |
1,123,645,275.00 |
| Capital Surplus |
2,655,849,996.00 |
| Surplus Reserve |
595,433,495.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,025,982,557.33 |
| Minority Stockholder's Interest |
550,215,892.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,444,704,969.96 |
| Owner's Equity（Stockholder's Equity） |
6,994,920,862.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,170,127,548.57 |
